We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging (CVMRI)

This study has been terminated.
(Principal Investigator is deceased)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00593541
First Posted: January 15, 2008
Last Update Posted: May 30, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of California, Davis
January 3, 2008
January 15, 2008
May 30, 2017
May 1999
July 2014   (Final data collection date for primary outcome measure)
Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR images [ Time Frame: Post-scanning ]
Same as current
Complete list of historical versions of study NCT00593541 on ClinicalTrials.gov Archive Site
Improve image quality by various techniques (e.g. reducing the effects of motion) [ Time Frame: Post-scanning ]
Same as current
Not Provided
Not Provided
 
Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging
Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging
This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.
This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.
Observational
Observational Model: Case-Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Noraml volunteers and patients with known or suspected cardiovascular disease
Abnormalities, Cardiovascular
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
42
July 2014
July 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older
  • Ability to give informed, written consent
  • Not Pregnant or breastfeeding

Exclusion Criteria:

  • Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers)
  • Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis
  • History of uncontrolled claustrophobia
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00593541
200210689
No
Not Provided
Not Provided
University of California, Davis
University of California, Davis
Not Provided
Principal Investigator: Michael H Buonocore, MD, PhD University of California, Davis
University of California, Davis
May 2017